CTI is ready to help bring your next drug to market
CTI has developed several Investigational New Drug (IND) applications utilizing electronic-Common Technical Document (eCTD) formats. We offer a seamless process from the earliest stages of drug development consulting through formal submission of documents electronically to regulatory agencies.
Serial submissions to the IND in eCTD formatOngoing eCTD maintenance includes but is not limited to:
CTI has the expertise needed to help our sponsors understand and comply with document submission requirements.